Wuwei Heavy Ion Center: Advancing Precision Radiotherapy for Healthy China

Wuwei Heavy Ion Center: Advancing Precision Radiotherapy for Healthy China

To further advance the Healthy China strategy, address core technologies in precision radiotherapy for cancer, fully leverage the disciplinary strengths of the Wuwei heavy ion program, and improve the level of personalized, comprehensive cancer care in Northwest China, the 2026 Precision Radiotherapy: Leading the Frontier – Clinical Applications and Academic Exchange Conference on Heavy Ion Therapy was successfully held on June 6 at the Heavy Ion Campus of Gansu Wuwei Cancer Hospital. Leading radiotherapy experts and professionals from across the province and beyond gathered to engage in in‑depth discussions on cutting‑edge technologies such as heavy ion therapy, CyberKnife, and radiation ablation, helping to establish a high‑level, multi‑disciplinary platform for academic exchange and collaboration.

At the conference, attendees listened to a keynote report titled "Wuwei Heavy Ions: Development and Practice." The report systematically summarized the achievements of the Heavy Ion Center in platform development, equipment operation and maintenance, case accumulation, technological iteration, and specialty construction. It presented the center's advantages using clinical data and practical cases, and outlined future directions for the discipline. Following the report, participating experts engaged in discussions and exchanges based on the current state of the field.

Zhang Yanshan, Vice President of Gansu Wuwei Cancer Hospital, delivering a speech

Zhang Yanshan, Vice President of Gansu Wuwei Cancer Hospital, presenting the report Wuwei Heavy Ions: Development and Practice

Experts engaged in discussion and exchange during the conference

The academic atmosphere was vibrant during the special lecture sessions, where several cutting‑edge clinical research findings were presented. Experts shared insights on radiation ablation technology, offering a comprehensive overview of its indications, procedural standards, and strategies for preventing and managing complications. Advantages and appropriate applications of the technology were discussed using real‑world clinical cases. In response to the high incidence of lung cancer, dedicated sessions addressed individualized heavy ion therapy for different pathological subtypes, discussing clinical outcomes, treatment strategies, and practical considerations. Following the presentations, participants engaged in in‑depth discussions focused on the challenges of heavy ion therapy for lung cancer and the optimization of treatment protocols.

Professor Chen Juhui from Fujian Cancer Hospital presenting on Clinical Practice and Exploration of Radiation Ablation

Zhang Yihe, Director of the First Department of Radiotherapy, Gansu Wuwei Cancer Hospital, presenting Heavy Ion Therapy for Lung Cancer

Experts engaged in discussion and exchange during the conference

Professor Bo Changwen from the First Hospital of Hebei Medical University presenting on Advantages and Clinical Practice of CyberKnife Technology

Professor Yin zhaosheng from the Second Department of Radiotherapy, Gansu Wuwei Cancer Hospital, presenting Heavy Ion Therapy for Adenoid Cystic Carcinoma

Experts engaged in discussion and exchange during the conference

The conference served not only as a platform for academic exchange but also as a reaffirmation of the hospital’s founding mission. In his keynote report, Professor Zhang Yanshan, Vice President of Gansu Wuwei Cancer Hospital, presented a comprehensive overview of the Wuwei Heavy Ion Center’s remarkable journey — from its challenging early days to its current state of excellence in equipment operations, a robust accumulation of clinical cases, and rapid technological iteration. The center has now established a fully integrated, end‑to‑end care system covering cancer screening, precision radiotherapy, and rehabilitation management. With robust clinical data and proven outcomes, it has not only secured a leading position in the field but has also become a trusted resource enabling cancer patients in Northwest China to receive world‑class treatment close to home. Moving forward, the hospital is taking a systematic approach to accelerate research on multi‑modality combination therapies, build a talent pipeline in precision radiotherapy, and transform the breakthrough success of heavy ion technology into a comprehensive, regional shield against cancer.

Conference participants spoke highly of the Wuwei Heavy Ion Center’s internationally advanced radiotherapy equipment, its standardized and comprehensive cancer care system, its comfortable and patient‑friendly environment, and its many original breakthroughs in heavy ion medical research and clinical application. They recognized that the leapfrog development of domestically produced heavy ion technology — from nothing to something, from following to leading — is a vivid illustration of China’s growing self‑reliance and self‑strengthening in science and technology.

The conference concluded successfully, further clarifying the future direction of precision radiotherapy and establishing a valuable platform for sharing clinical experience across the region. Looking ahead, Gansu Wuwei Cancer Hospital will continue to build on the strengths of its heavy ion platform, deepen the development of precision radiotherapy as a discipline, accelerate the clinical translation of cutting‑edge technologies, and refine its fully integrated care system covering screening, precision radiotherapy, and post‑treatment rehabilitation. Through high‑quality medical technology, the hospital remains committed to protecting public health and driving the high‑quality development of cancer prevention and treatment in Northwest China.

Conference Highlights

Writer: Guo Yishan, Zhang Jie

First Review: Zhang Jie

Second Review: Guo Yishan

Third Review: Cai Qinghua

Wuwei Cancer Hospital of Gansu Province (Wuwei Institute of Medical Sciences)

（甘）医广【2025】第11-14-387号